v.231201
Showing details for project SYSMHC00034
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00034_DR2b |
1 |
Human |
|
|
DRB1_1501 |
Detailed view of sample SYSMHC00034_DR2b
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00034 |
SYSMHC00034_DR2b |
DR2b.tar.gz |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class II |
DRB1_1501 |
28871256 |
native |
Mild acid elution |
B8.11.2 (IgG2b) |
Triple-TOF 5600 |
nano-LC ultra HPLC |
no |
DDA |
CID |
|
|
|
1 |